Tempest Therapeutics to hold 2026 annual meeting
- Annual meeting on November 9, 2026
- Election of two directors: Dr. John David Yee and Mr. William Drake Richey
- Ratify Ernst & Young LLP as auditors for 2026
Every EDGAR filing for Tempest Therapeutics, Inc. (TPST), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Nancy Freda Smith, new insider at TPST
Nancy Freda Smith
Matthew Angel, insider filing for TPST
Matthew Angel, reporting
John D. Yee, insider filing for TPST
John D. Yee, reporting
William Drake Richey, new insider at TPST
William Drake Richey, reporting
William Drake Richey, insider filing for TPST
William Drake Richey, reporting
Securities offering
Justin Trojanowski, insider filing for TPST
Justin Trojanowski, reporting